Some older patients may receive screening for breast or prostate cancer even though the tests aren't recommended because they aren't expected to live long enough to benefit from treatment, a U.S. study suggests.Read More
Study showed many were able to avoid graft-versus-host diseaseRead More
Surgery, radiation, chemotherapy, hormone therapy: these are the tools our doctors use to fight cancer. Of the four, chemotherapy (“chemo”) is probably the most fraught with patient anxiety. Will my hair fall out? Will I spend months vomiting? Here are the facts you need to know before you start chemotherapy.Read More
Rising levels of obesity and unhealthy weights could be linked to 670,000 extra cases of cancer in the next 20 years, a UK report predicts.Read More
Researchers suspect drug may help prevent spread of deadly disease
Men who take aspirin regularly may have a lower risk of dying from prostate cancer, a new study suggests.Read More
Skin checks are an important part of finding and treating skin cancer early. Many people notice some changes but wait several months before making an appointment with a dermatologist either because they want to see if there are further changes or because they are scared to get answers.Read More
Single dose of magic mushroom ingredient did months of good for cancer patients, study finds
People who receive life-threatening cancer diagnoses and find themselves battling depression and anxiety might consider munching on magic mushrooms, and that's not coming from a snake oil salesman.Read More
Doctors say there is now "encouraging" evidence that an annual blood test may cut ovarian cancer deaths by a fifth.
Ovarian tumours are often deadly as they are caught too late.Read More
Procedure showed promise on tumors under 3/4 of an inch, but more study is needed
Using a laser to heat and destroy tumors -- called laser ablation -- may be an effective way to treat small breast cancers, potentially saving some women from a lumpectomy, new research suggests.Read More
The UK is paying less for new cancer drugs than a number of other high-income countries, according to a report in The Lancet Oncology.
While the UK, Greece, Spain and Portugal pay the least, on average, for the drugs they use, Germany, Sweden and Switzerland pay the most.Read More